Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$101.80+0.08 (+0.08%)
Close on Nov 17, 2026Market cap $6.64BP/E 24.6Yield –
Lantheus market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Lantheus's market cap was $6.63B on Nov 11, 2026, against $4.23B a year earlier. Over the last 5 years it ranged from $1.72B to $7.77B, with a median of $5.10B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $6.63B | +38.8% |
| 2025 | Dec 31, 2025 | $4.78B | -24.6% |
| 2024 | Dec 31, 2024 | $6.34B | +46.5% |
| 2023 | Dec 29, 2023 | $4.33B | +23.4% |
| 2022 | Dec 30, 2022 | $3.51B | +79.4% |
| 2021 | Dec 31, 2021 | $1.95B | +116.8% |
| 2020 | Dec 31, 2020 | $901.81M | +12.1% |
| 2019 | Dec 31, 2019 | $804.59M | +33.7% |
| 2018 | Dec 31, 2018 | $601.95M | -21.5% |
| 2017 | Dec 29, 2017 | $766.83M | +149.7% |
| 2016 | Dec 30, 2016 | $307.15M | +199.3% |
| 2015 | Dec 31, 2015 | $102.63M | – |
See a number that looks wrong?